About this role
Amsterdam UMC Research Field Medical sciences » Medicine Researcher Profile First Stage Researcher (R1) Application Deadline 5 Oct 2026 - 21:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description For this position, the recruiting organisation is the Medicines Evaluation Board (MEB) in Utrecht, the Netherlands. You will be employed by the MEB and embedded in the POLARIS consortium. You will be supervised by Dr Marjon Pasmooij and work closely with the Amsterdam Leukodystrophy Center at Amsterdam UMC and the Amsterdam UMC platform Medicijn voor de Maatschappij, a partner of RARE-NL. You will initiate and conduct several studies on regulatory pathways and sustainable access to innovative therapies for rare diseases. Your research will address: - regulatory, organisational and scientific factors that influence the development of orphan medicines in academic settings; - requirements for small-scale ("n-of-few") manufacturing and quality control of advanced therapy medicinal products (ATMPs); - patient-reported outcomes relevant to leukodystrophy therapies; - cross-border access and reimbursement pathways for innovative therapies in Europe. You will use a combination of regulatory document analysis, expert interviews and case studies. This will allow you to bring together different scientific perspectives and contribute to knowledge that can support the development and accessibility of therapies for rare diseases. As part of the POLARIS network, you will also undertake secondments. These will provide hands-on experience in regulatory science and orphan-drug analysis at Amsterdam UMC platform Medicijn voor de Maatschappij, as well as experience with cross-border access and reimbursement w...